Click for best price
Prostate Cancer Screening Market Size, Share 2024
| Market size in 2023 |
US$ 12670 million
|
Forecast Market size by 2030 |
US$ 21810 million
|
| Growth Rate |
CAGR of 8.0% |
Number of Pages |
100 Pages |
This research report provides a comprehensive analysis of the Prostate Cancer Screening market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Prostate Cancer Screening market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Prostate Cancer Screening, challenges faced by the industry, and potential opportunities for market players.
The global Prostate Cancer Screening market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Prostate Cancer Screening market presents opportunities for various stakeholders, including Hospitals, Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Prostate Cancer Screening market. Additionally, the growing consumer demand present avenues for market expansion.
The global Prostate Cancer Screening market was valued at US$ 12670 million in 2023 and is projected to reach US$ 21810 million by 2030, at a CAGR of 8.0% during the forecast period.
The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measurement of prostate-specific antigen in the blood.
Key Features:
The research report on the Prostate Cancer Screening market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Prostate Cancer Screening market.
Market Overview: The report provides a comprehensive overview of the Prostate Cancer Screening market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Physical Exam, Laboratory Tests), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Prostate Cancer Screening market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Prostate Cancer Screening market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Prostate Cancer Screening market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Prostate Cancer Screening market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Prostate Cancer Screening market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Prostate Cancer Screening market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Prostate Cancer Screening, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Prostate Cancer Screening market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Prostate Cancer Screening market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Physical Exam
Laboratory Tests
Imaging Tests
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam
Biopsy
Market segment by Application
Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Global Prostate Cancer Screening Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Abbott Laboratories
Almac
Bayer
Beckman Coulter
Biom?Rieux
Genomic Health
Mayo Clinic
Mdxhealth
Roche Diagnostics
Rosetta Genomics
Thermo Fisher Scientific
Hologic
Myriad Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Screening, market overview.
Chapter 2: Global Prostate Cancer Screening market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Screening company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Screening Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 12670 million
|
| Forecast Market size by 2030 |
US$ 21810 million
|
| Growth Rate |
CAGR of 8.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
100 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Screening Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Screening Overall Market Size
2.1 Global Prostate Cancer Screening Market Size: 2023 VS 2030
2.2 Global Prostate Cancer Screening Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Screening Players in Global Market
3.2 Top Global Prostate Cancer Screening Companies Ranked by Revenue
3.3 Global Prostate Cancer Screening Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Screening Companies in Global Market, by Revenue in 2023
3.5 Global Companies Prostate Cancer Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Screening Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Screening Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Screening Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Screening Market Size Markets, 2023 & 2030
4.1.2 Physical Exam
4.1.3 Laboratory Tests
4.1.4 Imaging Tests
4.1.5 Gleason Score
4.1.6 TNM Score
4.1.7 Genetic Tests
4.1.8 Digital Rectal Exam
4.1.9 Biopsy
4.2 By Type - Global Prostate Cancer Screening Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Screening Revenue, 2019-2024
4.2.2 By Type - Global Prostate Cancer Screening Revenue, 2025-2030
4.2.3 By Type - Global Prostate Cancer Screening Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Screening Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Labs
5.1.5 Cancer Institutes
5.1.6 Diagnostic Centers
5.1.7 Others
5.2 By Application - Global Prostate Cancer Screening Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Screening Revenue, 2019-2024
5.2.2 By Application - Global Prostate Cancer Screening Revenue, 2025-2030
5.2.3 By Application - Global Prostate Cancer Screening Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Screening Market Size, 2023 & 2030
6.2 By Region - Global Prostate Cancer Screening Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Screening Revenue, 2019-2024
6.2.2 By Region - Global Prostate Cancer Screening Revenue, 2025-2030
6.2.3 By Region - Global Prostate Cancer Screening Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Prostate Cancer Screening Revenue, 2019-2030
6.3.2 US Prostate Cancer Screening Market Size, 2019-2030
6.3.3 Canada Prostate Cancer Screening Market Size, 2019-2030
6.3.4 Mexico Prostate Cancer Screening Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Screening Revenue, 2019-2030
6.4.2 Germany Prostate Cancer Screening Market Size, 2019-2030
6.4.3 France Prostate Cancer Screening Market Size, 2019-2030
6.4.4 U.K. Prostate Cancer Screening Market Size, 2019-2030
6.4.5 Italy Prostate Cancer Screening Market Size, 2019-2030
6.4.6 Russia Prostate Cancer Screening Market Size, 2019-2030
6.4.7 Nordic Countries Prostate Cancer Screening Market Size, 2019-2030
6.4.8 Benelux Prostate Cancer Screening Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Screening Revenue, 2019-2030
6.5.2 China Prostate Cancer Screening Market Size, 2019-2030
6.5.3 Japan Prostate Cancer Screening Market Size, 2019-2030
6.5.4 South Korea Prostate Cancer Screening Market Size, 2019-2030
6.5.5 Southeast Asia Prostate Cancer Screening Market Size, 2019-2030
6.5.6 India Prostate Cancer Screening Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Prostate Cancer Screening Revenue, 2019-2030
6.6.2 Brazil Prostate Cancer Screening Market Size, 2019-2030
6.6.3 Argentina Prostate Cancer Screening Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Screening Revenue, 2019-2030
6.7.2 Turkey Prostate Cancer Screening Market Size, 2019-2030
6.7.3 Israel Prostate Cancer Screening Market Size, 2019-2030
6.7.4 Saudi Arabia Prostate Cancer Screening Market Size, 2019-2030
6.7.5 UAE Prostate Cancer Screening Market Size, 2019-2030
7 Prostate Cancer Screening Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Prostate Cancer Screening Major Product Offerings
7.1.4 Abbott Laboratories Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Almac
7.2.1 Almac Company Summary
7.2.2 Almac Business Overview
7.2.3 Almac Prostate Cancer Screening Major Product Offerings
7.2.4 Almac Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.2.5 Almac Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Prostate Cancer Screening Major Product Offerings
7.3.4 Bayer Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.3.5 Bayer Key News & Latest Developments
7.4 Beckman Coulter
7.4.1 Beckman Coulter Company Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Prostate Cancer Screening Major Product Offerings
7.4.4 Beckman Coulter Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.4.5 Beckman Coulter Key News & Latest Developments
7.5 Biom?Rieux
7.5.1 Biom?Rieux Company Summary
7.5.2 Biom?Rieux Business Overview
7.5.3 Biom?Rieux Prostate Cancer Screening Major Product Offerings
7.5.4 Biom?Rieux Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.5.5 Biom?Rieux Key News & Latest Developments
7.6 Genomic Health
7.6.1 Genomic Health Company Summary
7.6.2 Genomic Health Business Overview
7.6.3 Genomic Health Prostate Cancer Screening Major Product Offerings
7.6.4 Genomic Health Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.6.5 Genomic Health Key News & Latest Developments
7.7 Mayo Clinic
7.7.1 Mayo Clinic Company Summary
7.7.2 Mayo Clinic Business Overview
7.7.3 Mayo Clinic Prostate Cancer Screening Major Product Offerings
7.7.4 Mayo Clinic Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.7.5 Mayo Clinic Key News & Latest Developments
7.8 Mdxhealth
7.8.1 Mdxhealth Company Summary
7.8.2 Mdxhealth Business Overview
7.8.3 Mdxhealth Prostate Cancer Screening Major Product Offerings
7.8.4 Mdxhealth Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.8.5 Mdxhealth Key News & Latest Developments
7.9 Roche Diagnostics
7.9.1 Roche Diagnostics Company Summary
7.9.2 Roche Diagnostics Business Overview
7.9.3 Roche Diagnostics Prostate Cancer Screening Major Product Offerings
7.9.4 Roche Diagnostics Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.9.5 Roche Diagnostics Key News & Latest Developments
7.10 Rosetta Genomics
7.10.1 Rosetta Genomics Company Summary
7.10.2 Rosetta Genomics Business Overview
7.10.3 Rosetta Genomics Prostate Cancer Screening Major Product Offerings
7.10.4 Rosetta Genomics Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.10.5 Rosetta Genomics Key News & Latest Developments
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Company Summary
7.11.2 Thermo Fisher Scientific Business Overview
7.11.3 Thermo Fisher Scientific Prostate Cancer Screening Major Product Offerings
7.11.4 Thermo Fisher Scientific Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.11.5 Thermo Fisher Scientific Key News & Latest Developments
7.12 Hologic
7.12.1 Hologic Company Summary
7.12.2 Hologic Business Overview
7.12.3 Hologic Prostate Cancer Screening Major Product Offerings
7.12.4 Hologic Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.12.5 Hologic Key News & Latest Developments
7.13 Myriad Genetics
7.13.1 Myriad Genetics Company Summary
7.13.2 Myriad Genetics Business Overview
7.13.3 Myriad Genetics Prostate Cancer Screening Major Product Offerings
7.13.4 Myriad Genetics Prostate Cancer Screening Revenue in Global Market (2019-2024)
7.13.5 Myriad Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Screening Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Screening Market Drivers in Global Market
Table 3. Prostate Cancer Screening Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Screening in Global Market
Table 5. Top Prostate Cancer Screening Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Prostate Cancer Screening Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Prostate Cancer Screening Revenue Share by Companies, 2019-2024
Table 8. Global Companies Prostate Cancer Screening Product Type
Table 9. List of Global Tier 1 Prostate Cancer Screening Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Screening Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Prostate Cancer Screening Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Prostate Cancer Screening Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Prostate Cancer Screening Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Prostate Cancer Screening Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Prostate Cancer Screening Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Prostate Cancer Screening Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Prostate Cancer Screening Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Prostate Cancer Screening Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Prostate Cancer Screening Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Prostate Cancer Screening Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Prostate Cancer Screening Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Prostate Cancer Screening Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Prostate Cancer Screening Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Prostate Cancer Screening Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Prostate Cancer Screening Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Prostate Cancer Screening Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Prostate Cancer Screening Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Prostate Cancer Screening Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Prostate Cancer Screening Revenue, (US$, Mn), 2025-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Prostate Cancer Screening Product Offerings
Table 32. Abbott Laboratories Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Almac Company Summary
Table 35. Almac Prostate Cancer Screening Product Offerings
Table 36. Almac Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 37. Almac Key News & Latest Developments
Table 38. Bayer Company Summary
Table 39. Bayer Prostate Cancer Screening Product Offerings
Table 40. Bayer Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 41. Bayer Key News & Latest Developments
Table 42. Beckman Coulter Company Summary
Table 43. Beckman Coulter Prostate Cancer Screening Product Offerings
Table 44. Beckman Coulter Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 45. Beckman Coulter Key News & Latest Developments
Table 46. Biom?Rieux Company Summary
Table 47. Biom?Rieux Prostate Cancer Screening Product Offerings
Table 48. Biom?Rieux Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 49. Biom?Rieux Key News & Latest Developments
Table 50. Genomic Health Company Summary
Table 51. Genomic Health Prostate Cancer Screening Product Offerings
Table 52. Genomic Health Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 53. Genomic Health Key News & Latest Developments
Table 54. Mayo Clinic Company Summary
Table 55. Mayo Clinic Prostate Cancer Screening Product Offerings
Table 56. Mayo Clinic Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 57. Mayo Clinic Key News & Latest Developments
Table 58. Mdxhealth Company Summary
Table 59. Mdxhealth Prostate Cancer Screening Product Offerings
Table 60. Mdxhealth Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 61. Mdxhealth Key News & Latest Developments
Table 62. Roche Diagnostics Company Summary
Table 63. Roche Diagnostics Prostate Cancer Screening Product Offerings
Table 64. Roche Diagnostics Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 65. Roche Diagnostics Key News & Latest Developments
Table 66. Rosetta Genomics Company Summary
Table 67. Rosetta Genomics Prostate Cancer Screening Product Offerings
Table 68. Rosetta Genomics Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 69. Rosetta Genomics Key News & Latest Developments
Table 70. Thermo Fisher Scientific Company Summary
Table 71. Thermo Fisher Scientific Prostate Cancer Screening Product Offerings
Table 72. Thermo Fisher Scientific Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 73. Thermo Fisher Scientific Key News & Latest Developments
Table 74. Hologic Company Summary
Table 75. Hologic Prostate Cancer Screening Product Offerings
Table 76. Hologic Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 77. Hologic Key News & Latest Developments
Table 78. Myriad Genetics Company Summary
Table 79. Myriad Genetics Prostate Cancer Screening Product Offerings
Table 80. Myriad Genetics Prostate Cancer Screening Revenue (US$, Mn) & (2019-2024)
Table 81. Myriad Genetics Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Screening Segment by Type in 2023
Figure 2. Prostate Cancer Screening Segment by Application in 2023
Figure 3. Global Prostate Cancer Screening Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Screening Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Prostate Cancer Screening Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Screening Revenue in 2023
Figure 8. By Type - Global Prostate Cancer Screening Revenue Market Share, 2019-2030
Figure 9. By Application - Global Prostate Cancer Screening Revenue Market Share, 2019-2030
Figure 10. By Type - Global Prostate Cancer Screening Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Prostate Cancer Screening Revenue Market Share, 2019-2030
Figure 12. By Application - Global Prostate Cancer Screening Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Prostate Cancer Screening Revenue Market Share, 2019-2030
Figure 14. By Region - Global Prostate Cancer Screening Revenue Market Share, 2019-2030
Figure 15. By Country - North America Prostate Cancer Screening Revenue Market Share, 2019-2030
Figure 16. US Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Prostate Cancer Screening Revenue Market Share, 2019-2030
Figure 20. Germany Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 21. France Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Prostate Cancer Screening Revenue Market Share, 2019-2030
Figure 28. China Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 32. India Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Prostate Cancer Screening Revenue Market Share, 2019-2030
Figure 34. Brazil Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Prostate Cancer Screening Revenue Market Share, 2019-2030
Figure 37. Turkey Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Prostate Cancer Screening Revenue, (US$, Mn), 2019-2030
Figure 41. Abbott Laboratories Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Almac Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Bayer Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Beckman Coulter Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Biom?Rieux Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Genomic Health Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Mayo Clinic Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Mdxhealth Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Roche Diagnostics Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Rosetta Genomics Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Thermo Fisher Scientific Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Hologic Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Myriad Genetics Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
